Related Experiment Video

Updated: Dec 21, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K

Reply to: "Hepatocellular carcinoma risk stratification in HBV cirrhosis: Time to turn the page"

Henry Lik-Yuen Chan1, Vincent Wai-Sun Wong1, Terry Cheuk-Fung Yip1

  • 1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong.

Journal of Hepatology
|May 20, 2020
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.8K

Related Experiment Videos

Last Updated: Dec 21, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.8K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K
Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
07:32

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

1.8K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

120
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120

Articles linked to this work by shared authors, journal, and citation graph.

Associations of RAS inhibitors and Calcium Channel Blockers with Liver Stiffness Dynamics and Long-term Liver-Related Events in MASLD.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Hepatocellular carcinoma surveillance in Europe: challenges and lessons from global practice.

The Lancet regional health. Europe·2026

A Markov model cost threshold analysis of potential hepatitis B virus cure regimens.

Clinical and translational gastroenterology·2026

Personalized Prediction of the Individual Risk of Liver-Related Events in Metabolic Dysfunction-Associated Steatotic Liver Disease Using the Dynamics of Noninvasive Tests.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026

Medical therapy of MASLD - consequences of the paradigm shift from histology to non-invasive tests.

JHEP reports : innovation in hepatology·2026

Hepatic Steatosis and Low-Density Lipoprotein Cholesterol Response After Statin Initiation: A Prospective Cohort Analysis.

Journal of gastroenterology and hepatology·2026

First-line durvalumab and tremelimumab in poor-prognosis unresectable hepatocellular carcinoma: Phase IIIb single-arm SIERRA study.

Journal of hepatology·2026

Effects of MASH risk genotypes on resmetirom efficacy in patients with MASH and fibrosis.

Journal of hepatology·2026

Temporal assessment of spatial and single-cell transcriptomes identifies CD226-NECTIN2 T cell-cholangiocyte interaction in bile duct inflammation.

Journal of hepatology·2026

Survival outcomes after liver transplantation in acute-on-chronic liver failure: A prospective study.

Journal of hepatology·2026

EASL-EASD-EASO Guidance for the Use of Resmetirom and Semaglutide as MASH-Targeted Therapy.

Journal of hepatology·2026

Multi-target blood test for hepatocellular carcinoma early detection: a cross-sectional analysis of the prospective ALTUS study.

Journal of hepatology·2026

Update of the practical guide for validation studies of automated cuff blood pressure monitors according to the Universal Standard by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization (ISO 81060-2:2018) and Amendments 1:2020 and 2:2024.

Journal of hypertension·2026

Coronary Vasculitis and Myocarditis in Acute Systemic Lupus Erythematosus Flares With Macrophage Activating Syndrome.

JACC. Case reports·2026

Durable Vessel Patency Achieved by Drug-Coated Balloon-Only Percutaneous Coronary Intervention in Triglyceride Deposit Cardiomyovasculopathy.

JACC. Case reports·2026

Preoperative Angiographic Washout and Coronary Artery Bypass Graft Patency.

JACC. Advances·2026

Is "No-Option Critical Limb Threatening Ischaemia" a Right Definition? A Paradigm Shift Driven by Autologous Cell Therapy for Diabetic Foot Disease.

The international journal of lower extremity wounds·2026

Directing mutant huntingtin towards degradation: Strategies and therapeutic opportunities.

Journal of Huntington's disease·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us